Korea vs South-East Asia (WHO region): New cases tested for RR-/MDR-TB
Korea
100.0%
in 2024
South-East Asia (WHO region)
91.0%
in 2024
Korea rank
1st
South-East Asia (WHO region) rank
1st
New cases tested for RR-/MDR-TB over time
- Korea
- South-East Asia (WHO region)
How they compare
Korea currently reports 100.0% against 91.0% in South-East Asia (WHO region), a difference of 9.0%.
That makes Korea's figure about 1.1 times South-East Asia (WHO region)'s.
Across all 13 years both countries report, Korea has been ahead every year.
Korea ranks 1st and South-East Asia (WHO region) ranks 1st of 192 countries.
Korea has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Korea | South-East Asia (WHO region) | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 78.6% | 27.5% | 51.1% | Korea |
| 2020s | 94.2% | 77.8% | 16.4% | Korea |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher new cases tested for rr-/mdr-tb, Korea or South-East Asia (WHO region)?
- Korea, at 100.0% against 91.0% in South-East Asia (WHO region) as of 2024.
- What is the difference in new cases tested for rr-/mdr-tb between Korea and South-East Asia (WHO region)?
- 9.0%, with Korea ahead.
- How many years of comparable data are there for Korea and South-East Asia (WHO region)?
- 13 years are reported by both, from 2011 to 2024.
- How do Korea and South-East Asia (WHO region) rank globally for new cases tested for rr-/mdr-tb?
- Korea ranks 1st and South-East Asia (WHO region) ranks 1st of 192 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as New cases tested for RR-/MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.